• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素耐药性综述:警钟敲响

A Review on Antibiotic Resistance: Alarm Bells are Ringing.

作者信息

Zaman Sojib Bin, Hussain Muhammed Awlad, Nye Rachel, Mehta Varshil, Mamun Kazi Taib, Hossain Naznin

机构信息

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh.

Projahnmo Study Site, Johns Hopkin's University Bangladesh.

出版信息

Cureus. 2017 Jun 28;9(6):e1403. doi: 10.7759/cureus.1403.

DOI:10.7759/cureus.1403
PMID:28852600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5573035/
Abstract

Antibiotics are the 'wonder drugs' to combat microbes. For decades, multiple varieties of antibiotics have not only been used for therapeutic purposes but practiced prophylactically across other industries such as agriculture and animal husbandry. Uncertainty has arisen, as microbes have become resistant to common antibiotics while the host remains unaware that antibiotic resistance has emerged. The aim of this review is to explore the origin, development, and the current state of antibiotic resistance, regulation, and challenges by examining available literature. We found that antibiotic resistance is increasing at an alarming rate. A growing list of infections i.e., pneumonia, tuberculosis, and gonorrhea are becoming harder and at times impossible to treat while antibiotics are becoming less effective. Antibiotic-resistant infections correlate with the level of antibiotic consumption. Non-judicial use of antibiotics is mostly responsible for making the microbes resistant. The antibiotic treatment repertoire for existing or emerging hard-to-treat multidrug-resistant bacterial infections is limited, resulting in high morbidity and mortality report. This review article reiterates the optimal use of antimicrobial medicines in human and animal health to reduce antibiotic resistance. Evidence from the literature suggests that the knowledge regarding antibiotic resistance in the population is still scarce. Therefore, the need of educating patients and the public is essential to fight against the antimicrobial resistance battle.

摘要

抗生素是对抗微生物的“神奇药物”。几十年来,多种抗生素不仅用于治疗目的,还在农业和畜牧业等其他行业中预防性使用。随着微生物对常见抗生素产生耐药性,而宿主却未意识到耐药性的出现,不确定性随之产生。本综述的目的是通过查阅现有文献,探讨抗生素耐药性的起源、发展、现状、监管及挑战。我们发现抗生素耐药性正以惊人的速度增长。越来越多的感染,如肺炎、结核病和淋病,治疗难度越来越大,有时甚至无法治疗,而抗生素的效果也越来越差。抗生素耐药性感染与抗生素使用水平相关。抗生素的非合理使用是导致微生物产生耐药性的主要原因。针对现有或新出现的难以治疗的多重耐药细菌感染的抗生素治疗方法有限,导致高发病率和高死亡率报告。这篇综述文章重申了在人类和动物健康中优化使用抗菌药物以减少抗生素耐药性的重要性。文献证据表明,公众对抗生素耐药性的了解仍然很少。因此,教育患者和公众对于抗击抗菌药物耐药性至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7797/5573035/a0e54c845c92/cureus-0009-00000001403-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7797/5573035/a0e54c845c92/cureus-0009-00000001403-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7797/5573035/a0e54c845c92/cureus-0009-00000001403-i01.jpg

相似文献

1
A Review on Antibiotic Resistance: Alarm Bells are Ringing.抗生素耐药性综述:警钟敲响
Cureus. 2017 Jun 28;9(6):e1403. doi: 10.7759/cureus.1403.
2
A Systematic Review of Antibiotic Resistance Trends and Treatment Options for Hospital-Acquired Multidrug-Resistant Infections.医院获得性多重耐药感染的抗生素耐药趋势及治疗选择的系统评价
Cureus. 2022 Oct 5;14(10):e29956. doi: 10.7759/cureus.29956. eCollection 2022 Oct.
3
Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance.抗多重耐药菌的抗生素增效剂:发现、研发及临床意义
Front Microbiol. 2022 Jul 1;13:887251. doi: 10.3389/fmicb.2022.887251. eCollection 2022.
4
Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.通过破坏细胞外蛋白质折叠来打破抗微生物药物耐药性。
Elife. 2022 Jan 13;11:e57974. doi: 10.7554/eLife.57974.
5
6
A new strategy to fight antimicrobial resistance: the revival of old antibiotics.对抗抗菌素耐药性的新策略:旧抗生素的复兴。
Front Microbiol. 2014 Oct 20;5:551. doi: 10.3389/fmicb.2014.00551. eCollection 2014.
7
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.微生物的抗生素耐药性:历史、机制、治疗策略和未来前景。
J Infect Public Health. 2021 Dec;14(12):1750-1766. doi: 10.1016/j.jiph.2021.10.020. Epub 2021 Oct 23.
8
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.抗生素耐药菌:现状与治疗选择,以加速新抗菌药物的研发。
Expert Rev Anti Infect Ther. 2022 Aug;20(8):1095-1108. doi: 10.1080/14787210.2022.2078308. Epub 2022 May 31.
9
Antimicrobial resistance of ocular microbes and the role of antimicrobial peptides.眼部微生物的抗菌耐药性和抗菌肽的作用。
Clin Exp Optom. 2021 Apr;104(3):295-307. doi: 10.1111/cxo.13125. Epub 2021 Mar 24.
10
Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.利用海洋天然产物作为平台来解决细菌耐药性和持久性问题。
Acc Chem Res. 2021 Apr 20;54(8):1866-1877. doi: 10.1021/acs.accounts.1c00007. Epub 2021 Mar 18.

引用本文的文献

1
Evaluation of current practice of antimicrobial use and clinical outcome in the management of pneumonia among pediatric patients admitted to Jimma Medical Center, Southwest Ethiopia: a prospective observational study.埃塞俄比亚西南部吉马医疗中心收治的小儿肺炎患者抗菌药物使用现状及临床结局评估:一项前瞻性观察研究
Ann Med Surg (Lond). 2025 Aug 5;87(9):5470-5481. doi: 10.1097/MS9.0000000000003690. eCollection 2025 Sep.
2
Development of a Bacterial Lysate from Antibiotic-Resistant Pathogens Causing Hospital Infections.由引起医院感染的耐药病原体开发细菌裂解物。
Microorganisms. 2025 Aug 6;13(8):1831. doi: 10.3390/microorganisms13081831.
3

本文引用的文献

1
Managing Neonatal and Early Childhood Syndromic Sepsis in Sub-District Hospitals in Resource Poor Settings: Improvement in Quality of Care through Introduction of a Package of Interventions in Rural Bangladesh.在资源匮乏地区的基层医院管理新生儿和儿童早期综合征性败血症:通过在孟加拉国农村地区引入一套干预措施提高护理质量
PLoS One. 2017 Jan 23;12(1):e0170267. doi: 10.1371/journal.pone.0170267. eCollection 2017.
2
A brief history of the antibiotic era: lessons learned and challenges for the future.抗生素时代简史:经验教训与未来挑战
Front Microbiol. 2010 Dec 8;1:134. doi: 10.3389/fmicb.2010.00134. eCollection 2010.
3
Mechanism of bactericidal efficacy against nosocomial pathogenic Staphylococcus aureus strain caused by fatty acids from Hermetia illucens larvae fat.
黑水虻幼虫脂肪中脂肪酸对医院致病性金黄色葡萄球菌菌株的杀菌作用机制
Sci Rep. 2025 Aug 19;15(1):30305. doi: 10.1038/s41598-025-15858-0.
4
α-Helical Structure of Antimicrobial Peptides Enhances Their Activity through Molecular Surface Signatures.抗菌肽的α-螺旋结构通过分子表面特征增强其活性。
Biochemistry. 2025 Aug 5;64(15):3311-3321. doi: 10.1021/acs.biochem.5c00101. Epub 2025 Jul 13.
5
RND/HAE-1 members in the Pseudomonadota phylum: exploring multidrug resistance.假单胞菌门中的RND/HAE-1成员:探索多重耐药性。
Biophys Rev. 2025 Mar 7;17(2):687-699. doi: 10.1007/s12551-025-01297-8. eCollection 2025 Apr.
6
Bioinspired Cationic Antimicrobial Polymers.仿生阳离子抗菌聚合物
Angew Chem Int Ed Engl. 2025 Jun 10;64(24):e202503738. doi: 10.1002/anie.202503738. Epub 2025 May 15.
7
Understanding therapeutic tolerance through a mathematical model of drug-induced resistance.通过药物诱导抗性的数学模型理解治疗耐受性。
NPJ Syst Biol Appl. 2025 Apr 10;11(1):30. doi: 10.1038/s41540-025-00511-3.
8
The Impact of COVID-19 on Healthcare Services, Risk Management, and Infection Prevention in Surgical Settings: A Qualitative Study.新型冠状病毒肺炎对手术环境下医疗服务、风险管理及感染预防的影响:一项定性研究
Healthcare (Basel). 2025 Mar 7;13(6):579. doi: 10.3390/healthcare13060579.
9
In Vitro and In Vivo Evaluation of the De Novo Designed Antimicrobial Peptide P6.2 Against a KPC-Producing Clinical Isolate.针对一株产KPC的临床分离株,对新设计的抗菌肽P6.2进行体外和体内评价。
Biomolecules. 2025 Feb 27;15(3):339. doi: 10.3390/biom15030339.
10
Antimicrobial Stewardship Impact on Antibiotic Use in Three Tertiary Hospitals in Zambia: A Comparative Point Prevalence Survey.抗菌药物管理对赞比亚三家三级医院抗生素使用的影响:一项比较性现患率调查
Antibiotics (Basel). 2025 Mar 10;14(3):284. doi: 10.3390/antibiotics14030284.
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.
新抗生素研发严重短缺,应对抗多药耐药菌-现在是采取行动的时候了。
Drug Resist Updat. 2011 Apr;14(2):118-24. doi: 10.1016/j.drup.2011.02.003. Epub 2011 Mar 23.
4
Origins and evolution of antibiotic resistance.抗生素耐药性的起源与演变。
Microbiol Mol Biol Rev. 2010 Sep;74(3):417-33. doi: 10.1128/MMBR.00016-10.
5
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.多柔比星脂质体与托泊替康联合治疗复发性卵巢癌。
J Clin Oncol. 2010 Jul 1;28(19):3107-14. doi: 10.1200/JCO.2009.25.4037. Epub 2010 Jun 1.
6
How antibiotics kill bacteria: from targets to networks.抗生素如何杀死细菌:从靶点到网络。
Nat Rev Microbiol. 2010 Jun;8(6):423-35. doi: 10.1038/nrmicro2333. Epub 2010 May 4.
7
Newer antibacterial drugs for a new century.新世纪的新型抗菌药物。
Expert Opin Investig Drugs. 2010 Feb;19(2):215-34. doi: 10.1517/13543780903505092.
8
Public education - a progress report.公共教育——一份进展报告。
J Antimicrob Chemother. 2007 Aug;60 Suppl 1:i53-5. doi: 10.1093/jac/dkm158.
9
Evolution and ecology of antibiotic resistance genes.抗生素抗性基因的进化与生态学
FEMS Microbiol Lett. 2007 Jun;271(2):147-61. doi: 10.1111/j.1574-6968.2007.00757.x. Epub 2007 May 8.
10
Is self-medication with antibiotics in Europe driven by prescribed use?欧洲的抗生素自我药疗是由处方药使用驱动的吗?
J Antimicrob Chemother. 2007 Jan;59(1):152-6. doi: 10.1093/jac/dkl457. Epub 2006 Nov 22.